Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

NNAL

Reference

Bernert JT, Pirkle JL, Xia Y, Jain RB, Ashley DL, Sampson EJ. Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2969-77.

Abstract

Background: The tobacco-specific nitrosamine NNK (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) and its reduction product in the body, NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol), are potent pulmonary carcinogens. We have measured total NNAL in the U.S. population of tobacco users and nonsmokers exposed to secondhand smoke (SHS).

Methods: We measured total urinary NNAL (free NNAL plus its glucuronides following hydrolysis) by using a sensitive and specific high-performance liquid chromatography / tandem mass spectrometry method. We calculated the percentage above the LOD, the 50th through 95th percentiles, and in some cases geometric means for groups classified by age, gender and race/ethnicity.

Results: Total urinary NNAL was measureable at or above its limit of detection (0.6 pg/mL) in 55% of the study participants, including 41% of nonsmokers. The population distribution of urinary NNAL included smoker and nonsmoker regions similar to the bimodal distribution of serum cotinine, and serum cotinine and total urinary NNAL were strongly correlated (r = 0.92; p < 0.001). Among nonsmokers, children had significantly higher concentrations of NNAL than did adults aged ≥20 years (p < 0.001).

Conclusions: Among NHANES participants, total NNAL was found at measurable levels in the urine of 41% of nonsmokers, and in 87.5% of those with substantial SHS exposure (with serum cotinine concentrations of 0.1 to 10 ng/mL). Children aged 6–11 years had the highest NNAL concentrations among all nonsmokers.

Impact: We describe for the first time the distribution of total urinary NNAL in the entire U.S. population including both smokers and nonsmokers. NNAL was detected in 41% of all nonsmokers.

Full Text

Download this publication [PDF - 464 KB]


 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #